Region: Switzerland

Switzerland’s government has used emergency powers to override the country’s merger control rules so as to allow Credit Suisse’s 11th hour sale to UBS, prompting criticism that competition laws have been ignored in the creation of a banking giant.

22 March 2023

Competition authorities in the EU, UK, US and Switzerland have heeded calls to better align cartel enforcement efforts by coordinating dawn raids on four fragrance manufacturers and a global industry association.

08 March 2023

A Swiss court has overturned and reduced fines on eight airlines for their alleged involvement in the global air cargo cartel, while ruling that the agency’s decision to stop them exchanging air freight information was “unconstitutional”.

19 January 2023

Featured in GCR 100 2023

Very few international firms have notable competition practices in Switzerland, where local powerhouses continue to work on long-running cartel and abuse of dominance probes before the country’s antitrust enforcer.

12 December 2022

Featured in Foreign Direct Investment Regulation Guide - Second Edition

Switzerland does not have a coherent legal framework for controlling foreign direct investment (FDI), but a new Draft Bill for FDI regulation presented by the Swiss Federal Council aims to change this.

06 December 2022

Switzerland’s Competition Commission is investigating if 34 banks violated the country’s cartel rules by exchanging information related to employee salaries, marking its first-ever foray into labour markets.

05 December 2022

Featured in Class actions hub

02 December 2022

Switzerland’s Competition Commission has appointed Laura Baudenbacher as its new president, marking the first time the authority has ever appointed a chair from private practice.

17 November 2022

Featured in The Guide to Life Sciences - First Edition

Reform of Swiss merger control may have consequences for future mergers in its life sciences sector, particularly in markets defined as national in geographical scope, such as the distribution of drugs markets.

21 October 2022

Switzerland’s Competition Commission is working alongside the European Commission to investigate whether Novartis abused one of its patents by launching legal proceedings over a treatment to fight skin disease.

15 September 2022